loading

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Forecast

The Connect Biopharma Holdings Ltd Adr (CNTB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $8.9214, representing a +801.16% increase from the current price of $0.99. The highest analyst price target is $8.8912, and the lowest is $8.9517.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNTB Price Target
Average 8.618 (+770.51% Upside)
loading

Is Connect Biopharma Holdings Ltd Adr (CNTB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 73.87 Sell
STOCH(9,6) 87.98 Sell
STOCHRSI(14) 88.86 Sell
MACD(12,26) 0.0585 Buy
ADX(14) 20.23 Neutral
William %R -15.33 Sell
CCI(14) 233.44 Buy
Buy: 2 Sell: 4 Neutral: 1
Summary: Sell
Moving Averages
Period Simple Exponential
MA10
0.8887
Buy
0.9284
Buy
MA20
0.8417
Buy
0.8714
Buy
MA50
0.7919
Buy
0.8266
Buy
MA100
0.8194
Buy
0.8565
Buy
MA200
0.9937
Buy
0.9761
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, CNTB could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 4 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on CNTB, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 73.87 indicates that CNTB is overbought. This suggests that CNTB price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
  2. STOCH (Stochastic Oscillator): The STOCH value of 87.98 indicates that CNTB is oversold. This means that CNTB price is at or near the highest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 88.86 indicates that CNTB is oversold. This suggests that CNTB price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 20.23 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 233.44 indicates that CNTB is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term CNTB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Connect Biopharma Holdings Ltd Adr financial reports and earnings history, Connect Biopharma Holdings Ltd Adr (CNTB) stock could reach $14.10 by 2030, $51.62 by 2040 and $101.02 by 2050. See the projected annual prices until 2050 of the Connect Biopharma Holdings Ltd Adr stock below:

  • Connect Biopharma Holdings Ltd Adr (CNTB) is expected to reach an average price of $50.31 in 2035, with a high prediction of $49.58 and a low estimate of $50.17. This indicates an $4,982% rise from the last recorded price of $0.99.
  • Connect Biopharma Holdings Ltd Adr (CNTB) stock is projected to chart a bullish course in 2040, with an average price target of $49.97, representing an $4,948% surge from its current level. The forecast ranges from a conservative $50.49 to a sky-high $51.62.
  • Our analysts predict Connect Biopharma Holdings Ltd Adr (CNTB) to jump 1,989% by 2045, soaring from $21.15 to an average price of $20.68, potentially reaching $22.76. While $21.15 is the low estimate, the potential upside is significant.
  • Connect Biopharma Holdings Ltd Adr (CNTB) stock is expected to climb by 2050, reaching an average of $99.65, a $9,965% jump from its current level. However, a wide range of estimates exists, with high and low targets of $101.02 and $99.87, respectively, highlighting the market's uncertainty.

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Year by Year Forecast

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2025

Connect Biopharma Holdings Ltd Adr Stock (CNTB) is expected to reach an average price of $5.3806 in 2025, with a high prediction of $10.67 and a low estimate of $0.095. This indicates an +443.49% rise from the last recorded price of $0.99.
Month Average Low High Change from today's price
July, 2025 $9.5912 $8.9517 $8.8912 +868.80%
August, 2025 $10.43 $10.53 $10.67 +953.60%
September, 2025 $10.18 $10.24 $10.32 +928.49%
October, 2025 $9.6049 $9.6444 $9.9349 +870.19%
November, 2025 $8.7738 $8.9738 $9.4892 +786.24%
December, 2025 $8.3481 $8.4981 $8.5487 +743.25%

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2026

The predicted value for Connect Biopharma Holdings Ltd Adr (CNTB) in 2026 is set at an average of $6.3053. Estimates vary from a peak of $8.2373 to a trough of $4.3733, indicating an +536.90% surge from the present price of $0.99.
Month Average Low High Change from today's price
January, 2026 $8.3276 $8.3327 $8.193 +741.17%
February, 2026 $8.1972 $8.2155 $8.2373 +728.00%
March, 2026 $7.9838 $8.0342 $8.1139 +706.44%
April, 2026 $7.5457 $7.5908 $7.8363 +662.19%
May, 2026 $6.8802 $7.0301 $7.3478 +594.97%
June, 2026 $6.5097 $6.5698 $6.51 +557.54%
July, 2026 $6.134 $6.1591 $6.4045 +519.59%
August, 2026 $5.7634 $5.9234 $5.9286 +482.17%
September, 2026 $5.1777 $5.3377 $5.5983 +423.00%
October, 2026 $4.8672 $5.0071 $5.1026 +391.64%
November, 2026 $4.6166 $4.6866 $4.7721 +366.33%
December, 2026 $4.351 $4.3733 $4.4615 +339.49%

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Connect Biopharma Holdings Ltd Adr (CNTB) is $8.1816, with a high forecast of $16.29 and a low forecast of $0.0746. This indicates an +726.43% increase from the last price of $0.99.
Month Average Low High Change from today's price
January, 2027 $4.1604 $4.1878 $4.2258 +320.24%
February, 2027 $3.8797 $3.8897 $4.0453 +291.89%
March, 2027 $3.1242 $3.3542 $3.7347 +215.57%
April, 2027 $2.2136 $2.5436 $2.709 +123.60%
May, 2027 $2.4831 $2.211 $2.3731 +150.81%
June, 2027 $1.9274 $1.9624 $2.3679 +94.68%
July, 2027 $1.5968 $1.6668 $1.7641 +61.29%
August, 2027 $1.1913 $1.3213 $1.5217 +20.33%
September, 2027 $0.7206 $0.8406 $1.061 -27.22%
October, 2027 $0.12 $0.0903 $0.8297 -87.88%
November, 2027 $15.64 $0.0746 $15.64 +1,480%
December, 2027 $17.02 $16.20 $16.29 +1,619%

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2028

In 2028, Connect Biopharma Holdings Ltd Adr (CNTB) is projected to reach an average price of $14.39, with a high projection of $22.85 and a low estimate of $5.9217. This indicates an +1,353% rise from the last price of $0.99.
Month Average Low High Change from today's price
January, 2028 $17.73 $17.28 $16.25 +1,691%
February, 2028 $12.91 $14.35 $17.10 +1,204%
March, 2028 $5.075 $9.075 $11.98 +412.63%
April, 2028 $8.1039 $9.1739 $6.4503 +718.58%
May, 2028 $6.4825 $7.4428 $6.0425 +554.80%
June, 2028 $10.60 $5.9217 $7.0623 +970.85%
July, 2028 $12.39 $12.86 $11.21 +1,152%
August, 2028 $22.87 $13.91 $22.85 +2,210%
September, 2028 $21.50 $22.59 $22.11 +2,072%
October, 2028 $21.68 $21.46 $21.08 +2,090%
November, 2028 $21.36 $21.06 $21.12 +2,057%
December, 2028 $19.48 $20.96 $21.01 +1,868%

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2029

The 2029 price forecast for Connect Biopharma Holdings Ltd Adr Stock (CNTB) is $18.27 on average, with a high prediction of $22.12 and a low estimate of $14.42. This represents an +1,745% increase from the previous price of $0.99.
Month Average Low High Change from today's price
January, 2029 $20.72 $20.80 $20.75 +1,993%
February, 2029 $22.15 $20.85 $22.12 +2,138%
March, 2029 $21.43 $21.47 $21.71 +2,064%
April, 2029 $20.67 $20.70 $21.09 +1,988%
May, 2029 $19.87 $19.89 $20.46 +1,907%
June, 2029 $18.53 $18.66 $19.16 +1,771%
July, 2029 $17.89 $18.02 $18.38 +1,707%
August, 2029 $17.56 $17.61 $17.74 +1,674%
September, 2029 $17.10 $17.17 $17.36 +1,628%
October, 2029 $16.23 $16.25 $16.81 +1,539%
November, 2029 $15.41 $15.51 $15.84 +1,457%
December, 2029 $14.35 $14.42 $15.10 +1,349%

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Price Forecast for 2030

Connect Biopharma Holdings Ltd Adr Stock (CNTB) is expected to reach an average price of $10.05 in 2030, with a high forecast of $14.10 and a low forecast of $5.9957. This signifies an +914.92% surge from the last price of $0.99.
Month Average Low High Change from today's price
January, 2030 $13.44 $13.63 $14.10 +1,257%
February, 2030 $13.09 $13.09 $13.17 +1,222%
March, 2030 $12.30 $12.37 $12.87 +1,142%
April, 2030 $11.59 $11.59 $12.05 +1,070%
May, 2030 $10.63 $10.88 $11.27 +974.12%
June, 2030 $10.07 $10.08 $10.36 +917.45%
July, 2030 $9.3814 $9.4114 $9.8025 +847.61%
August, 2030 $8.8202 $8.8225 $9.1625 +790.93%
September, 2030 $8.1201 $8.3143 $8.61 +720.22%
October, 2030 $6.6361 $7.0677 $7.6989 +570.31%
November, 2030 $6.1167 $5.9994 $6.0475 +517.84%
December, 2030 $5.7818 $5.9957 $5.9664 +484.02%
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
Cap:     |  Volume (24h):